(-0.02%) 5 296.14 points
(0.07%) 39 897 points
(-0.03%) 16 694 points
(0.34%) $79.50
(3.21%) $2.58
(1.36%) $2 417.90
(3.75%) $31.00
(1.62%) $1 088.70
(0.01%) $0.920
(-0.08%) $10.69
(-0.25%) $0.787
(0.16%) $91.02
@ $1.715
Issued: 9 Feb 2024 @ 11:54
Return: -2.92%
Previous signal: Feb 9 - 10:42
Previous signal:
Return: 0.42 %
Live Chart Being Loaded With Signals
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases...
Stats | |
---|---|
Today's Volume | 81 621.00 |
Average Volume | 278 346 |
Market Cap | 55.65M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.170 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.770 |
ATR14 | $0.00300 (0.18%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-14 | Leonard Braden Michael | Buy | 335 000 | Common Stock |
2024-05-14 | Leonard Braden Michael | Buy | 79 281 | Common Stock |
2024-05-14 | Leonard Braden Michael | Buy | 0 | Common Stock |
2024-05-14 | Leonard Braden Michael | Sell | 0 | Common Stock |
2023-08-28 | Hall Ashley | Sell | 15 625 | Stock option (right to buy) |
INSIDER POWER |
---|
71.18 |
Last 94 transactions |
Buy: 16 229 361 | Sell: 47 287 756 |
Volume Correlation
Reneo Pharmaceuticals, Correlation
10 Most Positive Correlations | |
---|---|
PYXS | 0.915 |
FRSX | 0.884 |
XPON | 0.867 |
SGTX | 0.851 |
XOG | 0.84 |
SGEN | 0.839 |
HJLI | 0.828 |
SATS | 0.827 |
NTRA | 0.822 |
STAB | 0.821 |
10 Most Negative Correlations | |
---|---|
ALT | -0.872 |
CERE | -0.85 |
LMRKN | -0.824 |
ISTR | -0.815 |
HOUR | -0.813 |
BSBK | -0.812 |
MYFW | -0.807 |
RNRG | -0.806 |
CFFN | -0.805 |
VWE | -0.805 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Reneo Pharmaceuticals, Correlation - Currency/Commodity
Reneo Pharmaceuticals, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-525 000 (0.00 %) |
EPS: | $-2.52 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-525 000 (0.00 %) |
EPS: | $-2.52 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-529 000 (0.00 %) |
EPS: | $-2.04 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-5.11 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Reneo Pharmaceuticals,
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators